These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 25793309
1. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms. Du J, Bandara HM, Du P, Huang H, Hoang K, Nguyen D, Mogarala SV, Smyth HD. Mol Pharm; 2015 May 04; 12(5):1544-53. PubMed ID: 25793309 [Abstract] [Full Text] [Related]
3. A New Class of Polyion Complex Vesicles (PIC-somes) to Improve Antimicrobial Activity of Tobramycin in Pseudomonas Aeruginosa Biofilms. Yildirim T, Bali A, Koch M, Paul P, Latta L, Schneider-Daum N, Gallei M, Lehr CM. Small; 2024 Oct 04; 20(40):e2401926. PubMed ID: 38829185 [Abstract] [Full Text] [Related]
4. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ. Int J Antimicrob Agents; 2008 Apr 04; 31(4):329-36. PubMed ID: 18280117 [Abstract] [Full Text] [Related]
5. Targeted treatment for biofilm-based infections using PEGylated tobramycin. Ding L, Wang G, Wang J, Peng Y, Cai S, Khan SU, Cui Z, Zhang X, Wu C, Smyth H. J Control Release; 2024 Aug 04; 372():43-58. PubMed ID: 38866243 [Abstract] [Full Text] [Related]
7. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO, Omri A. Int J Pharm; 2009 May 21; 373(1-2):141-6. PubMed ID: 19429299 [Abstract] [Full Text] [Related]
8. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa. Alipour M, Dorval C, Suntres ZE, Omri A. J Pharm Pharmacol; 2011 Aug 21; 63(8):999-1007. PubMed ID: 21718282 [Abstract] [Full Text] [Related]
15. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. Díez-Aguilar M, Morosini MI, Köksal E, Oliver A, Ekkelenkamp M, Cantón R. Antimicrob Agents Chemother; 2018 Jan 21; 62(1):. PubMed ID: 29084746 [Abstract] [Full Text] [Related]
16. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Tseng BS, Zhang W, Harrison JJ, Quach TP, Song JL, Penterman J, Singh PK, Chopp DL, Packman AI, Parsek MR. Environ Microbiol; 2013 Oct 21; 15(10):2865-78. PubMed ID: 23751003 [Abstract] [Full Text] [Related]
19. Combating Pseudomonas aeruginosa Biofilms by a Chitosan-PEG-Peptide Conjugate via Changes in Assembled Structure. Ju X, Chen J, Zhou M, Zhu M, Li Z, Gao S, Ou J, Xu D, Wu M, Jiang S, Hu Y, Tian Y, Niu Z. ACS Appl Mater Interfaces; 2020 Mar 25; 12(12):13731-13738. PubMed ID: 32155326 [Abstract] [Full Text] [Related]